![](https://endpts.com/wp-content/uploads/2021/03/Lonnie-Moulder-1-scaled.jpg)
Lonnie Moulder
Exclusive: Two M&A deals and $9B later, Lonnie Moulder is ramping up his latest biotech startup. And this one comes with global vision built in
Lonnie Moulder may have been in silent running mode in the 2 years since he closed the $5 billion sale of Tesaro to GlaxoSmithKline …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.